細胞解離用トリプシン-EDTA溶液市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競合別、2020～2030年

世界の細胞解離用トリプシン-EDTA溶液市場は、2024年に18億9,000万米ドルと評価され、2030年には27億4,000万米ドルに達し、CAGR 6.33％で成長すると予測されています。

同市場は、研究およびバイオ医薬品用途における細胞培養技術の需要増加を背景に大きく成長しています。トリプシン-EDTAは、サブカルチャリングや実験的手順中に培養表面から接着細胞を剥離できるようにすることで、細胞解離において重要な役割を果たしています。再生医療、組織工学、幹細胞研究の採用が増加していることが、高品質の細胞解離液の需要に拍車をかけています。製薬会社やバイオテクノロジー企業は、創薬、毒性試験、ワクチン製造を強化するために先進的な細胞培養法に投資しており、市場の成長をさらに後押ししています。学術研究機関や受託研究機関（CRO）も、精密医療や疾患モデリングにおける細胞培養技術の新たな応用を模索して貢献しています。

市場概要
予測期間	2026-2030
市場規模：2024年	18億9,000万米ドル
市場規模：2030年	27億4,000万米ドル
CAGR：2025年～2030年	6.33%
急成長セグメント	ワクチン製造
最大市場	北米

バイオ医薬品の研究開発への投資が増加し、信頼性が高く効率的な細胞解離ソリューションの需要がさらに高まっています。企業が生物製剤、モノクローナル抗体、遺伝子治療に注力する中、高品質の細胞培養試薬に対する需要が急増しています。薬剤スクリーニングや毒性評価のための細胞ベースのアッセイの拡大も、市場の成長を後押ししています。酵素製剤の技術的進歩により、より効率的で細胞毒性の少ない解離液が開発され、細胞の生存率と再現性が向上しています。動物由来製品を取り巻く規制上の懸念や倫理的配慮から、無血清や動物由来成分を含まない製剤の出現が勢いを増しています。しかし、細胞培養試薬の厳格な品質管理基準や規制当局の承認は、メーカーにとって課題となっています。また、酵素活性のばらつきや解離時の細胞損傷の可能性も、継続的な技術革新と標準化を必要とする懸念事項です。

主要市場促進要因：

主な市場課題：

主な市場動向：

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の細胞解離用トリプシン-EDTA溶液市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（0.25%溶液、0.05%溶液）
  • 用途別（インスリン製造、ワクチン製造、細胞培養、その他）
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 用途別
  • 地域別

第5章 アジア太平洋地域の細胞解離用トリプシン-EDTA溶液市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の細胞解離用トリプシン-EDTA溶液市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の細胞解離用トリプシン-EDTA溶液市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の細胞解離用トリプシン-EDTA溶液市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの細胞解離用トリプシン-EDTA溶液市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の細胞解離用トリプシン-EDTA溶液市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific Inc（Gibco）
• Lonza Group Ltd
• Merck KGa
• Sartorius AG
• Biosera Europe
• Fujifilm（Irvine Scientific）
• Chargen Life Sciences LLP
• ScienCell Research Laboratories, Inc
• STEMCELL Technologies Canada Inc.
• PromoCell GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Trypsin-EDTA Solution for Cell Dissociation Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.74 billion by 2030, growing at a CAGR of 6.33%. The market is experiencing substantial growth driven by the increasing demand for cell culture techniques in research and biopharmaceutical applications. Trypsin-EDTA plays a vital role in cell dissociation by enabling the detachment of adherent cells from culture surfaces during subculturing or experimental procedures. The rising adoption of regenerative medicine, tissue engineering, and stem cell research has fueled the demand for high-quality dissociation solutions. Pharmaceutical and biotechnology companies are investing in advanced cell culture methods to enhance drug discovery, toxicity testing, and vaccine production, further supporting market growth. Academic research institutions and contract research organizations (CROs) are also contributing by exploring new applications of cell culture technologies in precision medicine and disease modeling.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.89 Billion
Market Size 2030	USD 2.74 Billion
CAGR 2025-2030	6.33%
Fastest Growing Segment	Vaccines Manufacturing
Largest Market	North America

Increasing investments in biopharmaceutical research and development are further driving the demand for reliable and efficient cell dissociation solutions. As companies focus on biologics, monoclonal antibodies, and gene therapy, the demand for high-quality cell culture reagents has surged. The expansion of cell-based assays for drug screening and toxicity evaluation is also propelling market growth. Technological advancements in enzyme formulations have led to more efficient and less cytotoxic dissociation solutions, improving cell viability and reproducibility. The emergence of serum-free and animal-origin-free formulations is gaining momentum due to regulatory concerns and ethical considerations surrounding animal-derived products. However, stringent quality control standards and regulatory approvals for cell culture reagents present challenges for manufacturers. Variability in enzyme activity and potential cellular damage during dissociation are also concerns requiring continuous innovation and standardization.

Key Market Drivers:

Expanding Scope of Cell-Based Research: The expanding scope of cell-based research is a primary driver of the Global Trypsin-EDTA Solution for Cell Dissociation Market. Cell-based research has become a cornerstone of numerous scientific fields, including regenerative medicine, cancer biology, drug discovery, and developmental biology. As researchers delve deeper into cellular processes, they heavily rely on trypsin-EDTA solutions for detaching adherent cells from culture surfaces. This step is critical for cell passage, subculturing, and harvesting, making trypsin-EDTA an essential reagent in laboratories globally.

One key factor accelerating market growth is the versatility of cell-based research. Researchers use cell cultures to study disease mechanisms, screen drug candidates, and develop advanced therapies, including stem cell-based treatments and immunotherapies. These innovations drive the demand for reliable dissociation reagents like trypsin-EDTA. Additionally, the expansion of cell-based research now involves interdisciplinary collaboration among academia, pharmaceutical companies, and biotechnology firms, further amplifying the need for cell culture reagents and propelling market growth.

As the scientific community continues to explore cellular mechanisms, the demand for advanced tools and reagents remains crucial, including not only the development of novel cell culture techniques but also the refinement of existing protocols. In this context, trypsin-EDTA solutions serve as a fundamental element to ensure the reliable isolation of cells for downstream experiments.

Key Market Challenges:

Regulatory and Quality Control Challenges: The Trypsin-EDTA Solution for Cell Dissociation Market faces increasing regulatory and quality control challenges that may impede its growth. Ensuring compliance with stringent regulatory standards is vital due to the critical role these solutions play in supporting innovative research and therapies.

Regulatory compliance is particularly crucial when the end applications include biopharmaceutical manufacturing or clinical use. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established strict quality and safety benchmarks. For manufacturers, navigating these complex regulations is time-consuming and resource-intensive, as compliance with one set of guidelines may not ensure acceptance in other regions, complicating global market expansion.

Equally important is the issue of consistent product quality. Researchers and manufacturers depend on trypsin-EDTA solutions to achieve consistent performance in cell culture, with any variability potentially jeopardizing research outcomes or manufacturing processes. This necessitates rigorous quality control measures, driving up production costs.

As the market grows, the demand for traceability and transparency is intensifying. Stakeholders seek detailed information about the origins of ingredients, especially regarding animal-derived components like traditional trypsin, driven by ethical sourcing concerns, which further complicates regulatory challenges.

Key Market Trends:

Increasing Demand for Cell-Based Research: The Global Trypsin-EDTA Solution for Cell Dissociation Market is experiencing substantial growth driven by the increasing demand for cell-based research. This research has become foundational in fields such as regenerative medicine, drug discovery, and molecular biology. As researchers explore cellular functions more deeply, the need for reliable dissociation reagents like trypsin-EDTA solutions has never been greater.

Cell-based research provides a versatile platform for studying diseases, testing potential drug candidates, and understanding biological processes. In this context, trypsin-EDTA solutions are essential, enabling efficient cell manipulation and analysis. This critical step supports applications like cell passage, subculturing, and harvesting.

As the scope of cell-based research continues to expand, the demand for trypsin-EDTA solutions has surged, making them a staple in laboratories globally. Whether investigating cancer mechanisms, developing regenerative therapies, or conducting basic cell studies, trypsin-EDTA remains a key tool for maintaining cells under optimal conditions for experimentation.

The importance of cell-based research extends beyond academia into the pharmaceutical and biotechnology sectors, which rely heavily on these techniques for drug development and biomanufacturing. As the biopharmaceutical sector grows, the need for high-quality dissociation reagents continues to rise, ensuring the consistency and reliability of cell culture processes.

Key Market Players:

• Thermo Fisher Scientific Inc. (Gibco)
• Lonza Group Ltd
• Merck KGaA
• Sartorius AG
• Biosera Europe
• Fujifilm (Irvine Scientific)
• Chargen Life Sciences LLP
• ScienCell Research Laboratories, Inc.
• STEMCELL Technologies Canada Inc.
• PromoCell GmbH

Report Scope: The Global Trypsin-EDTA Solution for Cell Dissociation Market is segmented as follows, with additional industry trends also detailed:

By Type:

• 0.25% Solution
• 0.05% Solution

By Application:

• Insulin Manufacturing
• Vaccine Manufacturing
• Cell Culture
• Other

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape: A detailed analysis of the major companies in the Global Trypsin-EDTA Solution for Cell Dissociation Market.

• Company Information: Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Trypsin-EDTA Solution for Cell Dissociation Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (0.25% Solution, 0.05% Solution)
  • 4.2.2. By Application (Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other)
  • 4.2.3. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Application
  • 4.3.3. By Region

5. Asia Pacific Trypsin-EDTA Solution for Cell Dissociation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Application
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Application
  • 5.3.2. India Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Application
  • 5.3.3. Australia Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Application
  • 5.3.4. Japan Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Application
  • 5.3.5. South Korea Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Application

6. Europe Trypsin-EDTA Solution for Cell Dissociation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Germany Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Spain Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
  • 6.3.4. Italy Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Application
  • 6.3.5. United Kingdom Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Application

7. North America Trypsin-EDTA Solution for Cell Dissociation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Mexico Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Canada Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application

8. South America Trypsin-EDTA Solution for Cell Dissociation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Argentina Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Colombia Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application

9. Middle East and Africa Trypsin-EDTA Solution for Cell Dissociation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Saudi Arabia Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. UAE Trypsin-EDTA Solution for Cell Dissociation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Trypsin-EDTA Solution for Cell Dissociation Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc (Gibco)
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Lonza Group Ltd
• 14.3. Merck KGa
• 14.4. Sartorius AG
• 14.5. Biosera Europe
• 14.6. Fujifilm (Irvine Scientific)
• 14.7. Chargen Life Sciences LLP
• 14.8. ScienCell Research Laboratories, Inc
• 14.9. STEMCELL Technologies Canada Inc.
• 14.10.PromoCell GmbH

15. Strategic Recommendations

16. About Us & Disclaimer